HALO

Halozyme Therapeutics, Inc. News Headlines

$8.77
*  
unch
unch
Get HALO Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    HALO After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip
5/13/2014 11:40:01 AM - Benzinga


Halozyme's Q1 Loss Widens - Analyst Blog
5/13/2014 9:54:00 AM - Zacks.com


Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic Alternatives
5/13/2014 9:28:06 AM - Benzinga


Pre-Market Most Active for May 13, 2014 : ALU, NRF, ING, OKS, FB, DTV, BAC, HSBC, QQQ, FCEL, HALO, GMCR
5/13/2014 7:39:53 AM - NASDAQ.com News


Cramer's Mad Money - Halliburton Feels The Turn (4/22/14)
4/23/2014 6:08:00 AM - Seeking Alpha


Healthcare Stocks Declining Again; Halozyme Giving Back Early Gains Linked to Citigroup 'Buy' Rating
4/15/2014 12:23:32 PM - MT Newswires


Sector Update: Healthcare
4/15/2014 12:15:49 PM - MT Newswires


Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View
4/15/2014 9:27:19 AM - Benzinga


Markets Falling? Get Your Defense Ready
4/14/2014 2:47:00 PM - Investopedia


Halozyme Study Under Clinical Hold - Analyst Blog
4/10/2014 4:40:01 PM - Zacks.com


Sector Update: Healthcare
4/9/2014 7:42:44 AM - MT Newswires


Sector Update: Health-Care Shares Higher Pre-Market; Intuitive Surgical Up 9% on Q1 Guidance
4/9/2014 7:41:42 AM - MT Newswires


Pre-Market Most Active for Apr 9, 2014 : NOK, FB, SIRI, AA, VZ, QQQ, SNY, BAC, GM, HALO, VOD, FCEL
4/9/2014 7:39:58 AM - NASDAQ.com News


Halozyme Falls on Phase II Study Halt - Analyst Blog
4/8/2014 11:10:01 AM - Zacks.com


What Is The Significance Of Thromboembolic Events For The Future Of Halozyme Therapeutics' PEGPH20?
4/7/2014 5:27:00 PM - Seeking Alpha


Friday's ETF Movers: GDXJ, XBI
4/4/2014 3:06:29 PM - BNK Invest


Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum Names
4/4/2014 2:47:36 PM - Benzinga


Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat Results
4/4/2014 11:55:12 AM - Benzinga


Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates
4/4/2014 9:14:52 AM - Benzinga


US Stocks Poised For Higher Close This Week; Mylan Reportedly Eyes Swedish Rival
4/4/2014 8:10:21 AM - MT Newswires


Stock Futures Edge Higher Even as Payroll Growth Slows, Jobless Rate Flat at 6.7%
4/4/2014 7:50:31 AM - MT Newswires


Pre-Market Most Active for Apr 4, 2014 : MU, BAC, QQQ, SEAS, HALO, WMC, FB, VOD, MYL, ALU, APC, BBL
4/4/2014 7:39:58 AM - NASDAQ.com News


EC Approves Roche/Halozyme's MabThera SC - Analyst Blog
3/31/2014 10:30:01 AM - Zacks.com


Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss
3/31/2014 9:35:05 AM - Benzinga


Notable Two Hundred Day Moving Average Cross - HALO
3/27/2014 12:15:17 PM - BNK Invest